Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19?
Immunology
[키워드] accelerated
activated
acute respiratory syndrome
advanced age
aging
Bearing
characterized
co-morbidity
coronavirus
Coronavirus disease 2019
COVID-19
COVID-19 treatment
demographic group
described
development
dysregulated
effective
exacerbate
Factor
feature
females
functional
Gender
group
high risk
highlight
immune dysfunction
Immune profile
immune response
immune system
Immunesenescence
inflammaging
Inflammatory
less
Lymphocytes
male
Monocytes
obese
obesity
occur
Older
pathogen
patients
phenotypic
Premature
question
response
risk factor
SARS-Cov_2
SARS-CoV-2
senescent
severe COVID-19
subject
susceptibility
T cells
T2D
therapeutic options
Treatment
type 2 diabete
[DOI] 10.3389/fimmu.2020.573662 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2020.573662 PMC 바로가기 [Article Type] Immunology